Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.48 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.45 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CASP1 | P29466 | 2/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL547869 | 0.89 | HTT (0.44) | HAO1MEN1NPC1POLBRAB9A | |
| SCHEMBL10740141 | 0.89 | HTT (0.44) | HAO1MEN1NPC1POLBRAB9A | |
| SCHEMBL11678689 | 0.89 | HTT (0.44) | HAO1MEN1NPC1POLBRAB9A | |
| SCHEMBL3438249 | 0.87 | HDAC1 (0.46) | HAO1KMT2AALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL6704196 | 0.85 | HAO1 (0.59) | HAO1KMT2AALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL3243130 | 0.85 | ESR2 (0.46) | ALDH1A1KDM4ESMN1; SMN2LMNACYP2A6 | |
| SCHEMBL4052078 | 0.82 | HRH3 (0.57) | MEN1NPC1POLBRAB9ABLM | |
| SCHEMBL4058957 | 0.82 | HRH3 (0.57) | MEN1NPC1POLBRAB9ABLM | |
| SCHEMBL11997230 | 0.80 | HRH3 (0.55) | MEN1NPC1POLBRAB9ABLM | |
| SCHEMBL4048737 | 0.80 | HRH3 (0.55) | MEN1NPC1POLBRAB9ABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368595-A1 | NOVEL MOLECULES | Xeniopro GmbH (DE) | 2025-12-04 | — | — | US | disclosed |
| CN-119954697-A | Aromatic molecules for the treatment of pathological conditions | 赛尼欧普罗有限责任公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119930483-A | Aromatic molecules for the treatment of pathological conditions | 赛尼欧普罗有限责任公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-118290322-A | Aromatic molecules for the treatment of pathological conditions | 赛尼欧普罗有限责任公司 | 2024-07-05 | — | — | CN | disclosed |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | Xeniopro GmbH (DE) | 2023-05-11 | — | — | US | disclosed |
| US-20220354949-A1 | NOVEL COMPOUNDS | Xeniopro GmbH (DE) | 2022-11-10 | — | — | US | disclosed |
| US-20220249500-A1 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | Xeniopro GmbH (DE) | 2022-08-11 | — | — | US | disclosed |
| EP-3840834-A2 | AROMATIC MOLECULES FOR USE IN THE TREATMENT OF PATHOLOGICAL CONDITIONS | Xeniopro GmbH (DE) | 2021-06-30 | — | — | EP | disclosed |
| EP-3841091-A1 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERATIVE ACTIVITY | Xeniopro GmbH (DE) | 2021-06-30 | — | — | EP | disclosed |
| CN-112930337-A | Antiproliferative phenoxy (hetero) aryl ethers | 赛尼欧普罗有限责任公司 | 2021-06-08 | — | — | CN | disclosed |
| CN-112888479-A | Aromatic molecules for the treatment of pathological conditions | 赛尼欧普罗有限责任公司 | 2021-06-01 | — | — | CN | disclosed |
| WO-2020039088-A2 | NOVEL COMPOUNDS | Xeniopro GmbH (DE) | 2020-02-27 | — | — | WO | disclosed |
| WO-2020039094-A1 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERATIVE ACTIVITY | Xeniopro GmbH (DE) | 2020-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220354949-A1 | NOVEL COMPOUNDS | MUSK, TYR, IKZF3 | HAO1 2538/4885PARP10 1501/4885PARP3 2650/4885 |
| US-20220249500-A1 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | AHR, MUSK, TYR | HAO1 739/4885PARP10 2271/4885PARP3 2019/4885 |
| US-20250368595-A1 | NOVEL MOLECULES | MUSK, IKZF3, TYR | HAO1 2858/4885PARP10 1273/4885PARP3 2581/4885 |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | AHR, MUSK, TYR | HAO1 739/4885PARP10 2271/4885PARP3 2019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.